These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36905119)

  • 1. An optimized SpCas9 high-fidelity variant for direct protein delivery.
    Pedrazzoli E; Bianchi A; Umbach A; Amistadi S; Brusson M; Frati G; Ciciani M; Badowska KA; Arosio D; Miccio A; Cereseto A; Casini A
    Mol Ther; 2023 Jul; 31(7):2257-2265. PubMed ID: 36905119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior Fidelity and Distinct Editing Outcomes of SaCas9 Compared with SpCas9 in Genome Editing.
    Yang ZX; Fu YW; Zhao JJ; Zhang F; Li SA; Zhao M; Wen W; Zhang L; Cheng T; Zhang JP; Zhang XB
    Genomics Proteomics Bioinformatics; 2023 Dec; 21(6):1206-1220. PubMed ID: 36549468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas ribonucleoprotein mediated homology-directed repair for efficient targeted genome editing in microalgae
    Naduthodi MIS; Mohanraju P; Südfeld C; D'Adamo S; Barbosa MJ; van der Oost J
    Biotechnol Biofuels; 2019; 12():66. PubMed ID: 30962821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A highly specific SpCas9 variant is identified by in vivo screening in yeast.
    Casini A; Olivieri M; Petris G; Montagna C; Reginato G; Maule G; Lorenzin F; Prandi D; Romanel A; Demichelis F; Inga A; Cereseto A
    Nat Biotechnol; 2018 Mar; 36(3):265-271. PubMed ID: 29431739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth assessment of the PAM compatibility and editing activities of Cas9 variants.
    Zhang W; Yin J; Zhang-Ding Z; Xin C; Liu M; Wang Y; Ai C; Hu J
    Nucleic Acids Res; 2021 Sep; 49(15):8785-8795. PubMed ID: 34133740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
    Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
    PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral Capsid-Mediated
    Lu Z; Yao X; Lyu P; Yadav M; Yoo K; Atala A; Lu B
    CRISPR J; 2021 Dec; 4(6):914-928. PubMed ID: 33733873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Efficient Expression and Purification Protocol for SpCas9 Nuclease and Evaluation of Different Delivery Methods of Ribonucleoprotein.
    Evmenov K; Pustogarov N; Panteleev D; Safin A; Alkalaeva E
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.
    Walther J; Porenta D; Wilbie D; Seinen C; Benne N; Yang Q; de Jong OG; Lei Z; Mastrobattista E
    Eur J Pharm Biopharm; 2024 Mar; 196():114207. PubMed ID: 38325664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells.
    Jurlina SL; Jones MK; Agarwal D; De La Toba DV; Kambli N; Su F; Martin HM; Anderson R; Wong RM; Seid J; Attaluri SV; Chow M; Wahlin KJ
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome Editing in Zebrafish Using High-Fidelity Cas9 Nucleases: Choosing the Right Nuclease for the Task.
    Prykhozhij SV; Cordeiro-Santanach A; Caceres L; Berman JN
    Methods Mol Biol; 2020; 2115():385-405. PubMed ID: 32006412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells.
    Vakulskas CA; Dever DP; Rettig GR; Turk R; Jacobi AM; Collingwood MA; Bode NM; McNeill MS; Yan S; Camarena J; Lee CM; Park SH; Wiebking V; Bak RO; Gomez-Ospina N; Pavel-Dinu M; Sun W; Bao G; Porteus MH; Behlke MA
    Nat Med; 2018 Aug; 24(8):1216-1224. PubMed ID: 30082871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.
    Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA
    Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic in vitro specificity profiling reveals nicking defects in natural and engineered CRISPR-Cas9 variants.
    Murugan K; Suresh SK; Seetharam AS; Severin AJ; Sashital DG
    Nucleic Acids Res; 2021 Apr; 49(7):4037-4053. PubMed ID: 33744974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Development of SpCas9 Variants with High Specificity and Efficiency Based on the HH Theory].
    Wang GH; Wang CM; Wu XJ; Chu T; Huang DW; Li J
    Mol Biol (Mosk); 2024; 58(1):157-159. PubMed ID: 38943587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Genome Editing with CRISPR-Cas9.
    Rahman S; Ikram AR; Azeem F; Tahir Ul Qamar M; Shaheen T; Mehboob-Ur-Rahman
    Methods Mol Biol; 2024; 2788():355-372. PubMed ID: 38656525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic Circular Dichroism of the Cas9 Protein and gRNA:Cas9 Ribonucleoprotein Complex.
    Halat M; Klimek-Chodacka M; Orleanska J; Baranska M; Baranski R
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.
    Zhang S; Shen J; Li D; Cheng Y
    Theranostics; 2021; 11(2):614-648. PubMed ID: 33391496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroporation of AsCpf1/RNP at the Zygote Stage is an Efficient Genome Editing Method to Generate Knock-Out Mice Deficient in Leukemia Inhibitory Factor.
    Kim YS; Kim GR; Park M; Yang SC; Park SH; Won JE; Lee JH; Shin HE; Song H; Kim HR
    Tissue Eng Regen Med; 2020 Feb; 17(1):45-53. PubMed ID: 32002841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.